Mobile

A randomized, double-blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-006220-20

A randomized, double-blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of an Intra Uterine Device. A phase II study

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the maximum pain intensity experienced by the patient during and within 10 minutes after start of IUD insertion when treated with SHACT in comparison to placebo using a 100 mm VAS scale.

Critère d'inclusion

  • Pain relief during insertion of an intra uterine device

Liens